You-Sun Kim

8PUBLICATIONS
11CO-AUTHORS
Molecular targetsImmunogenetics (incl. genetic immunology)Cell development, proliferation and deathInnate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 08, 2025
Optogenetically Activatable MLKL as a Standalone Functional Module for Necroptosis and Therapeutic Applications in Antitumoral Immunity.

Da-Hye Jeong, Seokhwi Kim, Han-Hee Park

|Mar 05, 2024
SIRT1 ISGylation accelerates tumor progression by unleashing SIRT1 from the inactive state to promote its deacetylase activity.

Ji An Kang, Yoon Jung Kim, Kyu Yun Jang

|Feb 02, 2024
NAMPT-Driven M2 Polarization of Tumor-Associated Macrophages Leads to an Immunosuppressive Microenvironment in Colorectal Cancer.

Sun Mi Hong, A-Yeon Lee, Byeong-Ju Kim

|Oct 12, 2022
Roles of RIPK3 in necroptosis, cell signaling, and disease.

Michael J Morgan, You-Sun Kim

|Sep 26, 2022
LCK-Mediated RIPK3 Activation Controls Double-Positive Thymocyte Proliferation and Restrains Thymic Lymphoma by Regulating the PP2A-ERK Axis.

Sung-Min Hwang, Yu-Jin Ha, Gi-Bang Koo

|Aug 22, 2021
RIPK3 activation induces TRIM28 derepression in cancer cells and enhances the anti-tumor microenvironment.

Han-Hee Park, Hwa-Ryeon Kim, Sang-Yeong Park

Pageof 2